This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Instytut Farmakologii Polskiej Akademii Nauk. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations of Tomasz Lenda in Serotonin Receptor Research.
Introduction
Tomasz Lenda is a notable inventor based in Krakow, Poland. He has made significant contributions to the field of pharmacology, particularly in the development of compounds that interact with serotonin receptors. His work focuses on creating new therapeutic options for disorders related to the central nervous system.
Latest Patents
Tomasz Lenda holds a patent for "Imidazolyl-substituted indole derivatives binding 5-HT7 serotonin receptor and pharmaceutical compositions thereof." This invention relates to a new class of substituted indole derivatives that activate the 5-HT serotonin receptor. These compounds exhibit high affinity and selectivity for the receptor while possessing favorable physicochemical properties. Notably, they are the first described low-basicity 5-HT receptor agonists. The invention also encompasses the use of these compounds in treating or preventing 5-HT receptor-related disorders, especially those affecting the central nervous system. Additionally, it includes isotopically labeled compounds for in vivo diagnostics or imaging of the 5-HT serotonin receptor.
Career Highlights
Tomasz Lenda is affiliated with the Institute of Pharmacology of the Polish Academy of Sciences. His research has led to advancements in understanding serotonin receptor interactions and their implications for therapeutic applications. He has been instrumental in developing innovative compounds that could potentially improve treatment outcomes for various neurological conditions.
Collaborations
Tomasz has collaborated with colleagues such as Adam Hogendorf and Agata Hogendorf, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Tomasz Lenda's work exemplifies the intersection of innovation and pharmacology, particularly in the realm of serotonin receptor research. His contributions are paving the way for new therapeutic strategies in treating central nervous system disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile